Shareholders' equity · 2011–2025
Myriad Genetics shareholders' equity
$368M−47.5% · FY2025
Myriad Genetics (MYGN) reported $368M in shareholders' equity for fiscal 2025, −47.5% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $368M | −47.5% | Open → |
| FY20242024-12-31 | $701M | −10.5% | Open → |
| FY20232023-12-31 | $783M | −11.6% | Open → |
| FY20222022-12-31 | $886M | −8.5% | Open → |
| FY20212021-12-31 | $968M | +9.9% | Open → |
| FY20202020-12-31 | $881M | −18.2% | Open → |
| FY20192019-12-31 | $1.1B | +1.2% | Open → |
| FY20182018-12-31 | $1.1B | +16.4% | Open → |
| FY20172017-12-31 | $914M | +24.7% | Open → |
| FY20162016-12-31 | $733M | −4.9% | Open → |
| FY20152015-12-31 | $771M | +11.0% | Open → |
| FY20142014-12-31 | $694M | +2.7% | Open → |
| FY20132013-12-31 | $676M | +2.1% | Open → |
| FY20122012-12-31 | $662M | +7.4% | Open → |
| FY20112011-12-31 | $617M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth −3.6%
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Myriad Genetics shareholders' equity |url=https://companiesranked.com/en/company/myriad-genetics/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Myriad Genetics shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/myriad-genetics/shareholders-equityBibTeX
@misc{companiesranked-en-company-myriad-genetics-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Myriad Genetics shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/myriad-genetics/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0000899923-26-000072 · July 31, 2026
{{cite web |title=Myriad Genetics shareholders' equity — 10-Q (0000899923-26-000072) |url=https://www.sec.gov/Archives/edgar/data/899923/000089992326000072/mygn-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-07-31}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.